NWPF

News ArchivesRead News

Michael J. Fox and Parkinson’s Disease

Thursday June 30, 2005

Exact causes still a mystery
Mary Kugler

About - Between one and one-and-a-half million Americans are affected by Parkinson’s disease, a disorder of the central nervous system. "Parkinson’s" is the overall term for at least six different categoriesof the disorder, which usually affects people age 50 or older.

About 10-20% of people with Parkinson’s are diagnosed before age 50; only half of these people are diagnosed before age 40. This is called juvenile Parkinson’s. Michael J. Fox, diagnosed at age 30 years old in 1991, is in this category.

Possible causes People with Parkinson’s disease have a shortage of a chemical that affects movement (called dopamine) in their brains.

Treatment of Parkinson’s disease has traditionally been with medication that can be made into dopamine in the brain (Sinemet), or by drugs that seem to affect the use of dopamine in the brain (Symmetrel, Eldepryl). Newer drugs, called dopamine agonists (Parlodel, Permax, Mirapex, Requip), activate dopamine-sensitive brain cells.

Surgical treatments One technique being investigated is high-frequency stimulation of a part of the brain called the subthalamic nucleus. This is known as deep brain stimulation. Brain tissue transplants using genetically-altered cells, fetal tissue, or pig tissue introduce cells to produce dopamine. New techniques for thalamotomy and pallidotomy, which destroy the "trouble-causing" cells in the brain using an electrode, are being developed.

Michael J. Fox has established The Michael J. Fox Foundation for Parkinson’s Research. He has spoken out in favor of stem cell research and has worked tirelessly to raise money for research. The Foundation Web site states, "Fox wholeheartedly believes that if there is a concentrated effort from the Parkinson’s community, elected representatives in Washington, DC, and (most importantly) the general public, researchers can pinpoint the cause of Parkinson’s and uncover a cure by 2010."

Recent News

Aug 28 - Brain cells 'burn out' in Parkinson's disease
Aug 24 - Study Details Process Involved in Parkinson’s Disease
Aug 24 - Google Reveals Gigantic Ambitions To Fight Cancer, Diabetes, Parkinson's, Heart Problems
Aug 20 - Two proteins work together to help cells eliminate trash; Parkinson's may result
Aug 17 - Scientists visualize critical part of basal ganglia pathways
Aug 17 - VA benefits office seeks all vets exposed to Agent Orange
Aug 12 - New, rapid dementia screening tool rivals 'gold standard' clinical evaluations
Aug 11 - Strolling in Seaside, fighting Parkinson's
Aug 11 - Scientists probing molecular origins of Parkinson's disease highlight two proteins
Aug 11 - Could Chocolate Help To Ease Parkinson’s Disease?
Aug 10 - Take 2: Why Seattle should try to replicate Spokane’s 3-on-3 Hoopfest success
Aug 10 - Book Review: A voyage into Parkinson’s disease, led by patient and journalist
Aug 10 - Parkinson's could be slowed with existing drug
Aug 7 - Opinion: Why modern life is making dementia in your 40s more likely
Aug 6 - Parkinson’s Disease Psychosis: My Husband’s Frightening Symptom
Aug 3 - Software Turns Smartphones into Tools for Medical Research
Jul 31 - Innovative Technology Using Dragonflies Might Offer Insights Into Human Brain Function
Jul 27 - Low-dose lithium reduces side effects from most common treatment for Parkinson's disease
Jul 27 - Opinion: Parkinson's disease creating class of workers who fear for their jobs: PennLive letters
Jul 22 - Parkinson's: Diabetes drug may offer clue to treatment